Please refer attached file

Piramal Pharma Ltd. has issued a clarification in response to a news article on NDTV Profit regarding a sudden spike in its share price. The company stated that the referenced news article does not contain any new material information requiring disclosure under SEBI Listing Regulations. Piramal Pharma affirmed that all relevant company information is already in the public domain, and no material events remain undisclosed. The company attributed the share price movement to market dynamics and is unaware of any specific reason driving the rally.